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DOI: 10.1039/c002420aA new and highly sensitive method for the determination of 239Pu in human urine has been
developed permitting the reassessment of planchets initially prepared for alpha spectrometry (AS)
analysis in the context of internal dosimetry. A set of urine samples (volume: 500 mL) was spiked with
known quantities of 239Pu, ranging from 2 to 120 fg (4.6 mBq–0.3 mBq), employing 14 pg (2.05 mBq) of
242Pu as internal standard. The Pu was purified by ion-chromatography using BioRad AG1X2
anion-exchange resins (Bio-Rad Laboratories Inc.). The chemical yield was determined by alpha-
spectrometry, being about 80%. Afterwards, the planchets so obtained were leached with diluted HNO3
and the dissolved plutonium was determined by Accelerator Mass Spectrometry (AMS) at the Centro
Nacional de Aceleradores (CNA) in Seville, Spain. The minimum detectable activity (MDA) for the
AMS measurements was determined through the study of a set of procedural blanks, giving figures
of about 0.44 fg (1 mBq) per sample. This contrasts with the MDA obtained by AS for the same set of
samples, of about 50 fg (0.1 mBq). The results now presented helps to demonstrate that the
routine measurement of 239Pu at ultra trace levels in human urine samples is possible with the
new-generation of compact AMS systems, offering a highly sensitive method for the reassessing of
planchets prepared for bioassay purposes.Introduction
Plutonium (Pu) comprises fifteen isotopes1 of which the 239Pu
(half-life: 24110 years) is the most important, being widely used
in civil and military applications due to its fissile nature. Moni-
toring of occupationally exposed workers to risk of radioactive
contamination is based on workplace and individual monitoring.
Individual monitoring can be achieved through in vivo and in
vitro measurements. Internal exposure to Pu is principally
assessed from in vitro measurements of the element excreted in
urine, feces, blood or biological secretions.2 The most common
method is the bioassay of urine samples, which involves the
processing of very large volumes of urine (typically 1.5–2 L), in
order to obtain a concentrated and purified fraction of Pu that
can be quantified by either Alpha-Spectrometry (AS) or Mass
Spectrometry (MS) techniques.
AS is the most widely used radioanalytical technique for the
determination of Pu isotopes in dosimetry studies.3,4 Its main
disadvantage is the relatively long counting time (from days to
weeks, depending on the precision required) that is necessary for
the final quantification of the plutonium, usually electro-
deposited onto stainless-steel planchets.
Another drawback is the impossibility of obtaining informa-
tion on the 240Pu/239Pu isotopic ratio, as the difference between the
alpha-energy emissions of both isotopes—240Pu: T1/2¼ 6564 y, Ea
(keV)¼ 5168 (76%) and 239Pu: T1/2 ¼ 24110 y, Ea (keV)¼ 5157aCentro de Investigaciones Energeticas, Medioambientales y Tecnologicas
(CIEMAT), Av. Complutense 22, 28040 Madrid, Spain. E-mail: abel.
yllera@ciemat.es; Tel: +34 91 346 65 82
bCentro Nacional de Aceleradores (CNA), Av. Thomas A. Edison, 41092
Sevilla, Spain
1410 | J. Anal. At. Spectrom., 2010, 25, 1410–1415(73.3%)—is smaller than the energy resolution of conventional
Passivated Implanted Planar Silicon (PIPS) detectors. This ratio
offers very useful information on the origin of the plutonium. The
typical Minimum Detectable Activity (MDA) for 239Pu obtained
by AS is about 50 fg of 239Pu/sample, or 0.1 mBq/sample. This is
about two orders of magnitude higher than the 239Pu activity
excreted by a person per litre of urine from the general pop-
ulation,5 which can be taken as the reference value to determine
the existence of additional intakes. The convenient reduction of
the MDA can be achieved by MS techniques, such as TIMS
(Thermal Ionization Mass Spectrometry), ICP-MS (Inductively-
Coupled Plasma Mass Spectrometry), RIMS (Resonance
Ionization Mass Spectrometry) and AMS (Accelerator Mass
Spectrometry).
TIMS and ICP-MS are widely employed for routine analysis
of Pu, providing accurate and precise results at very low
concentrations.6,7 However, sample preparation protocols for
TIMS analysis are very time-consuming in comparison with ICP-
MS. Currently, the most widely used technique for the determi-
nation of actinides remains AS. However, ICP-MS has been
gaining ground in this area due to its multi-elemental analytical
capability, speed of analysis and increasingly lower limit of
detection (LOD). More recently, the employ of high resolution
instruments (sector-field ICP-MS) coupled with innovative
feeding systems for sample introduction has provided better
sensitivity and accuracy in the determination of Pu isotopes at
femtogram levels.6,8–11 The major disadvantage in high resolution
ICP-MS analysis for 239Pu appears when there is also U in the
sample, due to the formation of 238U1H+ polyatomic ions in the
plasma during the ionization process, which would demand
a resolution of m/Dm 37000 for resolving the peaks. Therefore,This journal is ª The Royal Society of Chemistry 2010
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View Article Onlinea very efficient chemical procedure is necessary to extract and
purify the plutonium fraction from the sample, usually based on
ion-chromatography methods.
In the last ten years, conventional AMS systems, based on 3 to
12 MV electrostatic tandem accelerators, have been increasingly
used for the precise and accurate determination of Pu isotope
ratios at ultra-trace levels. Among the different MS techniques,
AMS is the best tool for interference discrimination, making it
possible to measure plutonium isotopes with almost any matrix
effect. A detailed description of AMS systems can be found in
Chamizo12 and the references therein. Shortly, almost all AMS
facilities can be understood as two mass spectrometers (called
‘‘injector’’ and ‘‘analyzer’’) linked with a tandem accelerator. The
radionuclide of interest is first prepared as a solid target, and then
injected into the system as a negative ion by ion sputtering (using
a Cs+ primary ion source). The sputtered negative ions that pass
the first cinematic filters are injected into the tandem accelerator,
where they experience the so-called stripping process, i.e., two or
more electrons are removed from each ion following the collision
of the beam with, usually, argon gas. That way, the molecules are
dissociated. The resulting positive atomic ions are then acceler-
ated back to ground potential in the high energy part of the
accelerator. Finally, the accelerated beam is mass and charge
analyzed through, usually a sector magnet and an electrostatic
deflector. The ions of interest are finally counted on a detector,
usually a multianode gas ionization chamber (Hellborg and
Skog13). Recently, compact AMS systems, working with terminal
voltages lower than 1 MV, have demonstrated their applicability
for Pu isotope determination at ultra-trace levels, making AMS
a cost-effective and a competitive technique compared to other
MS facilities in this field.14 In the Table 1, a comparison between
the MDA, the sample preparation time, and the time devoted per
analysis for the different MS techniques is shown, and also
compared against AS.
In this paper, we demonstrate the capabilities of the 1 MV AMS
system at the CNA, the second compact AMS in the world with
the potential to measure actinides, for the measurement of 239Pu in
urine samples at ultra-trace levels. The experimental details and
the obtained results are discussed in the following sections.Experimental
Standards, reagents and resins
The 239Pu and 242Pu spikes were obtained from two certified
solutions supplied by the National Physical Laboratory (NPL,Table 1 Comparative MDA and time needed for sample preparation and
radiometric techniques
Analytical Method Sample Preparation time Analysis time
AS 2–3 days 4 days
TIMS 3–4 days 20–30 min.
ICP-MS 12 h 5–10 min.
SF-ICP-MS 1–2 days 5–10 min.
AMS 1–2 days 30–40 min.
This journal is ª The Royal Society of Chemistry 2010England). They were diluted with 2 M HNO3 to obtain stock
solutions with a concentration of 20.3 mBq mL1
(140.4 pg mL1) of 242Pu and 7.9 mBq mL1 (3.4 pg mL1) of
239Pu. All reagents (salts and solutions) were prepared using
analytical grade reagents from Merck and high purity Milli-Q
water (Millipore Iberica). Certipur iron ICP standard (Merck)
and 500 mesh pure aluminium powder (Alfa-Aesar) were
employed for preparation of the AMS cathodes. AG-1X2 ion-
chromatography resin (Bio-Rad Laboratories) was used for the
purification of the plutonium.Samples
The 24 h urine samples were collected from several healthy adult
volunteers. The samples were divided in aliquots of 500 mL and
spiked with known amounts of 242Pu (14 pg, used as internal
reference) and 239Pu (in the range from 2 to 120 fg) at the moment
of the collection. The sample preparation procedure is shown in
the diagram of Fig. 1 and is explained in the following para-
graphs.Sample mineralization and chemical separation of Pu
Samples were mineralized by microwave digestion (Milestone,
Model ETHOS-1) in Teflon closed vessels using 15 mL of 8 M
HNO3 and 5 mL of H2O2 per sample. A temperature programme
was selected: the final set value, 200 C was reached in 10 min and
maintained for 30 min. Once cooled, the resulting residue was
dissolved with 30 mL of 8 M HNO3, being ready for the radio-
chemical purification.
Ion-exchange resins were prepared as follows: aliquots of 10 g
of Bio-Rad AG1X2 resin were introduced into a 50 mL chro-
matography glass column and washed with 100 mL of Milli-Q
water and 200 mL of 8 M HNO3 to condition the matrix to the
nitrate form. The sample (30 mL in 8 M HNO3 matrix) was then
loaded into the column, and the eluted fraction (corresponding
to U) was discarded. Then, sequential steps were followed for
purification: elution with 50 mL of 8 M HNO3 to strip the Am
and Sr fractions; elution of Th with 50 mL of concentrated HCl
and, finally, addition of 0.20 g of hydroxylamine hydrochloride
and plutonium elution with 50 mL of 0.5 M HCl.Electrodeposition
All the samples were prepared according to the Hallstadius
method.15 Firstly, the purified solution with the Pu fraction wasdetermination of 239Pu in human urine using mass spectrometric and
MDA (fg/mBq) Reference (Instrument)
87–130/200-300 Ref. 21
0.53/1.2 Ref. 7
1.7/3.8 Ref. 23
130/300 Ref. 24 (Agilent HP-4500)
16/37 Ref. 9 (Element-2/APEX nebulizer)
1/2.3 Ref. 6 (Element-2/DIHEN nebulizer)
0.35/0.82 Ref. 26 (6.5 MV tandem accelerator)
0.22/0.51 Ref. 25 (10 MV tandem accelerator)
1/2.3 Ref. 14 (0.6 MV tandem accelerator)
J. Anal. At. Spectrom., 2010, 25, 1410–1415 | 1411
Fig. 1 Schematic diagram of the urine samples preparation procedure and the time required for every process.
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View Article Onlineevaporated to dryness. Wet-ashing of the residue was carried out
by adding 3 mL of concentrated HNO3 and baking to dryness.
Then, 1 mL of 0.3 M sodium sulfite was added. The resulting
solution was then evaporated to dryness and 0.3 mL of concen-
trated sulfuric acid and 4 mL of Milli-Q grade water were added.
The solution was then adjusted to pH ¼ 2.5 with concentrated
ammonium hydroxide and 5 mL of 1% sulfuric acid were added
to the sample to avoid the eventual adsorption of the actinides
onto the electrodeposition cell-walls. The pH of the electrolyte
was adjusted to 2.1–2.5 with ammonium hydroxide.
In our experimental set-up, the electrodeposition was per-
formed onto mirror polished stainless steel disks (2.5 cm dia-
meter, 1 mm thickness), which acts as cathode of the electrolysis
cell, while the anode was a platinum wire. During the procedure,
a density current of 0.52 A cm2 was set and the electrodes were
kept at 7 mm distance. This resulted in a deposit covering an area
of approximately 2.2 cm diameter.16
Recovery of Pu from planchets and preparation of samples for
AMS
Once the samples were measured by AS, every planchet was
submerged in 10 mL of 3 M HNO3 overnight in order to recover
the electrodeposited Pu. After that, the resulting solution was
evaporated to dryness and dissolved with 2 mL of 8 M HNO3 to
proceed with the AMS sample preparation. Firstly, the former
solution was transferred to 30 mL centrifuge Teflon tubes. After
the addition of 1 mg of Fe3+, which acts as the final carrier for the
plutonium, the solution was once again evaporated to dryness,
and the residue was transferred to 5 mL crucibles as shown in
Fig. 2. Then, the sample was baked at 800 C in a muffle furnace
(Milestone, Model PYRO) for 3 h, to transform the plutonium
and iron to oxides (Pu3O8, Fe2O3). Finally, 1 mg of 500 mesh
pure aluminium powder was properly homogenized with the1412 | J. Anal. At. Spectrom., 2010, 25, 1410–1415oxides and the resulting mixture was pressed into a 1.3 mm
diameter aluminium cathode. That way, the samples were ready
to be measured by AMS.17
Analysis
Alpha spectrometry. Alpha spectrometry was performed with
PIPS detectors. These detectors have an active area of 450 mm2
and the nominal alpha-peak energy resolution, expressed as full
width at half-maximum (FWHM), is 18 keV. The planchets
(Pu sources) were placed at 1.5 mm from the detector surface.
For the evaluation of the spectra, the Genie 2000 v.2.2 software
(Canberra) was used.
Accelerator mass spectrometry. The AMS determinations were
performed at the 1 MV compact AMS facility at the Centro
Nacional de Aceleradores (CNA) in Seville, Spain (Fig. 3).
Details about the technique can be found in Chamizo et al.18
Briefly, the plutonium isotopes are extracted from the sample
as PuO in the Cs+ sputter ion source; mass analyzed with a 90
sector magnet; stripped to Pu3+ in an Argon gas stripper with
0.1 mg cm2 mass thickness in the terminal of the accelerator,
working at 670 kV; and finally charged, energy, and mass
analyzed with a 90 sector magnet and a 120 electrostatic
deflector with spherical electrodes. The ions of interest are
counted from the total energy signal provided by the detector,
a gas ionization chamber with a 30 nm thickness silicon nitride
window. The spectrum so obtained is displayed in Fig. 3, together
with the different measurement details. Pulsing times of 5 s for
242Pu and 15 s for 239Pu are used, adding up to 20 min of analysis
per sample. On the whole, about 11% of the plutonium ions
extracted from source are transmitted to the detector. A sample
containing 1 pg of plutonium produces a typical count rate of
100 cps for about 30–40 min. The 239Pu/238U mass suppressionThis journal is ª The Royal Society of Chemistry 2010
Fig. 2 Pictures showing the steps involved in the AMS cathode preparation process: (a) dry iron residue obtained after the evaporation of the purified
plutonium solution with 1 mg of iron; (b) iron oxide obtained after baking at 800 C the former residue; (c) images of the cathode where the final iron
oxide plus aluminium mixture is pressed.
Fig. 3 Diagram of the 1 MV AMS facility SARA at the CNA, together
with the Pu isotopes measurement details. In the final spectrum, X2+
represents the molecular fragments in the 2+ charge state with the same
M/q as the ions of interest. They pass the cinematic filters, but can be
discriminated in terms of their total energy in the detector.
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View Article Onlinefactor is about 109, which means that a sample containing 1 mg of
238U produces a typical 239Pu background of 1 fg.Results and discussion
Optimization of the treatment and radiochemical separation
The volume of urine for the analysis of Pu has been optimized as
described in previous studies,19,20 which were carried out as an
alternative to the classic methods using 24 h excretion. In this
work, a maximum volume of 500 mL of urine was employed
because it was optimal to evaporate, mineralize (by microwave
digestion) and finally to perform the Pu measurements in
a reasonably short time (500 mL corresponds to the volume of
the first excretion in the morning, more or less). The improve-
ments obtained when compared with the routine procedures used
for the analysis of plutonium isotopes, are basically the reduction
of the time needed for the sample preparation. The preparation
process including microwave digestion lasted between 5 and 7 h
(Fig. 1). Regarding to the radiochemical separation of Pu, the
purification with AG1X2 resin is a standard method, which isThis journal is ª The Royal Society of Chemistry 2010commonly used for the internal dosimetry monitoring of occu-
pationally exposed workers. This method has been largely veri-
fied in several intercomparison exercises, with good results
concerning to Pu separation and recovery.21 The main advantage
of this method is the fast and effective separation of Pu from
other radioisotopes (Am, Sr, Th, and U). In our case the time
necessary to complete the Pu purification was about 3 h.Alpha measurements
Table 2 summarizes MDA and LOD for 239Pu and 242Pu obtained
from the analysis of a set of 50 blank urine samples measured by
AS. LODs were calculated using the Currie criteria,22 and the
evaluation of MDA was achieved by applying the following the
formula:
MDA ¼ 4:65 sB þ 3
T
 100
3
 100
R
 1000
V
where: MDA¼ minimum detectable activity (Bq/sample), T ¼
counting time (s), e¼ counting efficiency (%), R ¼ mean value of
the chemical recovery yield (%), sB¼ standard deviation of the
blank counts, V ¼ analyzed volume of urine (mL).
Then, the LODs were translated into MDAs taking into
account that the counting efficiency was 33.9  1.4%, the back-
ground ranges were between 0 and 3 counts for a counting time
of 350 000 s, and a radiochemical yield of 82  5%.
An example of alpha spectrum for a urine sample processed
with this method is presented in the Fig. 4.Reassessing of planchets by AMS
Some of the planchets, previously measured by AS, were chosen
for reassessing. The selection criteria used was to measure those
samples corresponding to the activity range below or near the
LOD for AS. It is also important to remark that the AMS
measurements were performed as a blind test.
Two different processes were tested to recover the Pu from the
planchets to re-evaluate it by AMS. In the first one, the extrac-
tion of Pu was attempted by dipping the planchets in 20 mL of an
acidic mixture (HNO3 2.5% v/v, and HCl 2.5% v/v) overnight.
Then, the planchet was rinsed with HNO3 2.5% v/v, the extract
was heated to dryness and, finally, the residue was used for
preparing the AMS cathodes. This residue contained a high
amount of iron oxide coming from the planchet (between 6 and
15 mg), so the samples were diluted at least six times more thanJ. Anal. At. Spectrom., 2010, 25, 1410–1415 | 1413
Table 2 LODs and MDAs for 239Pu and 242Pu in sample blanks and urine
LOD MDA
239Pu 242Pu 239Pu 242Pu
AS mBq/sample 44.8  5.0 56.8  11.9 117.3  12.8 134.5  18.7
fg/sample 19.4  2.2 387.6  81.2 50.9  5.6 918.1  127.8
AMSa mBq/sample 0.57  0.23 0.150  0.059 1.25  0.46 0.32  0.12
fg/sample 0.20  0.08 0.830  0.033 0.44  0.16 1.76  0.66
a Data given in the LOD columns for Pu by AMS corresponds to the ‘‘critical level’’ as defined by Currie22 as LC ¼ 2.33(sB1/2).
Fig. 4 Alpha spectrum obtained from a urine sample (S8* in the Table
3), spiked with 242Pu and 239Pu.
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View Article Onlineusual. Therefore, the obtained 239Pu and 242Pu count rates were
significantly reduced. This explains the poorer accuracy obtained
for samples marked with an asterisk in the Table 3.
In the second process, the planchets were treated with 20 mL of
HNO3 5% v/v (HCl was not used), in the same way as described
above. In this case, almost any iron was extracted from the
planchets, and the samples produced the expected count-rates.
Therefore, for reassessing purposes using AMS, the use of HCl
must be avoided.
Fourteen unspiked urine samples (procedural blanks) were
prepared and 239Pu and 242Pu were measured by AMS (see Table
2). The corresponding LOD’s were calculated from the obtained
count rates considering as well the statistical criterium given in
Currie,22 and they were traduced into 239Pu and 242Pu mass in the
sample considering the efficiency of the measurement. ThisTable 3 Experimental results for AS and AMS measurements. Accuracy is
Samples Spiked 239Pu/mBq Spiked 239Pu/fg Recovery yield 242Pu (%
S1 4.9 2.0 80
S2 9.9 3.9 76
S3 14.8 5.9 83
S3a 14.8 5.9 93
S4 19.7 7.8 79
S5 29.6 11.8 82
S6 39.5 15.7 77
S6a 39.5 15.7 77
S7a 98.6 39.2 83
S8a 295.9 117.6 89
a Samples affected by the high Fe content from planchet corrosion during ac
1414 | J. Anal. At. Spectrom., 2010, 25, 1410–1415efficiency, which strongly depends on the experimental set-up,
was estimated measuring a set of three samples spiked with well-
known amounts of 239Pu and 242Pu during the same experiment.
On average, a sample containing 1 pg of plutonium produced
about 100  10 cps in the detector. Finally, these LOD’s were
traduced into MDA’s considering the yield of the chemical
procedure, as determined by alpha-spectrometry (R), and the
measurement time (T ¼ 20 min), according to the following
formula:
MDA ¼ 4:65  sB þ 3
T
 1pgðPuÞ
100cps
 100
R
where MDA¼ minimum detectable activity (pg/sample) and sB
is the square root of the total number of counts produced by the
procedural blanks for any isotope during the measurement. The
obtained MDA’s are displayed in Table 3.
It is interesting to mention that the procedural blanks
produced the same 239Pu and 242Pu count-rates as the instru-
mental blanks (high-purity iron-oxide mixed with aluminium),
which means that any additional Pu was introduced during the
sample processing. The main limitation in this case was the
background introduced by the ion source due to cross contami-
nation effects, with a contribution factor of about 103 between
neighboring samples. During our experiments, this background
was introduced by the standards (samples with a certified Pu
isotopic composition), which have to be measured every half an
hour to control the stability and reliability of the measurements.
Conclusions
The possibility of reassess the 239Pu in urine samples by AMS
starting from electrodeposited planchets, initially prepared forexpressed as 2s
) Measured 239Pu by AS (fg)
Planchet reassessing of 239Pu by
AMS (fg)
below LOD 2.2  1.2
below LOD 4.1  0.8
below LOD 6.2  1.4
below LOD 5.4  2.8
below LOD 8.7  1.2
below LOD 14.6  2.8
below LOD 17.7  2.2
below LOD 15.4  4.2
35.3  8.1 41.6  7.8
114.8  14.6 92.7  8.4
id attack with HNO3/HCl.
This journal is ª The Royal Society of Chemistry 2010
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View Article OnlineAS measurement, has been studied in this work. The results
obtained demonstrate the feasibility of such reassessment with
very good sensitivity and reliability: the reported MDA for AMS
reassessment being 0.44  0.16 fg/sample, far lower than for AS,
which is of the order of 50.9  5.6 fg/sample. The work was
undertaken after the good results obtained by using AMS for the
quantification of 239Pu in urine samples obtained in a previous
work.20 AMS is an extremely sensitive technique which makes
feasible to handle smaller volumes of urine, thereby significantly
reducing both the time of preparation as well as the time required
for measurement of Pu content in the sample. The possibility of
reassessing planchets that could not be quantified by conven-
tional AS, because the activity of Pu is lower than the MDA of
this radioanalytical technique, is a new and exciting possibility
for the proper quantification of Pu incorporation in humans.References
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